Authors :
Tarun Kumar; Kuldeep saini; Peeush Singhal
Volume/Issue :
Volume 7 - 2022, Issue 5 - May
Google Scholar :
https://bit.ly/3IIfn9N
Scribd :
https://bit.ly/3n8QOKy
DOI :
https://doi.org/10.5281/zenodo.6691298
Abstract :
A smart drug delivery system consists of
intelligent nanocarriers, process selection, and relaxation
techniques. This study highlights the recent novel
development of Smart Drug Delivery Systems for a
variety of technical nanocarriers, including liposomes,
micelles, dendrimers, mesoporous silica nanoparticles,
gold nanoparticles, super paramagnetic iron oxide
nanoparticles, carbon nanotubes, and quantum dots and
their impact on cancer treatments. This study is expected
to be of widespread interest to those who are looking for
new future research in this field and to those who are
about to start their research into smart nano-carrierbased drug delivery. Smart Drug Delivery Systems could
distribute drugs to low-dose sites and regulate means to
remove the side effects that are otherwise induced by
traditional drug delivery systems. Chemotherapy is
widely used for treating cancer, which would be the
world's second-largest cause of death.” Choosing the
best strategies for cancer cell detection follows the
selection of an acceptable kind of nanocarrier. SDDs
identify cancer sites by using the physiochemical
variations between cancer cells and healthy cells. The
location of the cancer cells is described precisely by two
main methods: passive targeting and active targeting.
Passive targeting allows for the cancer site to be
recognized implicitly by using the Enhanced
Permeability (EPR) effect. Active targeting uses cancer
cell surface receptors which are over expressed
specifically for targeting cancer cells. The next move is to
discharge drugs at a particular concentration at the
stated site. Drugs can be released by external or internal
stimulation from nanocarriers, depending on the shape
and smartness of nano-carriers
Keywords :
Novel techniques, smart drugs delivery system (SDDS), cancer, treatment, challenges.
A smart drug delivery system consists of
intelligent nanocarriers, process selection, and relaxation
techniques. This study highlights the recent novel
development of Smart Drug Delivery Systems for a
variety of technical nanocarriers, including liposomes,
micelles, dendrimers, mesoporous silica nanoparticles,
gold nanoparticles, super paramagnetic iron oxide
nanoparticles, carbon nanotubes, and quantum dots and
their impact on cancer treatments. This study is expected
to be of widespread interest to those who are looking for
new future research in this field and to those who are
about to start their research into smart nano-carrierbased drug delivery. Smart Drug Delivery Systems could
distribute drugs to low-dose sites and regulate means to
remove the side effects that are otherwise induced by
traditional drug delivery systems. Chemotherapy is
widely used for treating cancer, which would be the
world's second-largest cause of death.” Choosing the
best strategies for cancer cell detection follows the
selection of an acceptable kind of nanocarrier. SDDs
identify cancer sites by using the physiochemical
variations between cancer cells and healthy cells. The
location of the cancer cells is described precisely by two
main methods: passive targeting and active targeting.
Passive targeting allows for the cancer site to be
recognized implicitly by using the Enhanced
Permeability (EPR) effect. Active targeting uses cancer
cell surface receptors which are over expressed
specifically for targeting cancer cells. The next move is to
discharge drugs at a particular concentration at the
stated site. Drugs can be released by external or internal
stimulation from nanocarriers, depending on the shape
and smartness of nano-carriers
Keywords :
Novel techniques, smart drugs delivery system (SDDS), cancer, treatment, challenges.
